Barclays analyst Saket Kalia maintains Tyler Technologies (NYSE:TYL) with a Equal-Weight and lowers the price target from $410 to $400.
Advent, Warburg Pincus Lead Multi-Billion Buyout Bid For Baxter’s BioPharma Solutions
A buyout consortium comprising Warburg Pincus and Advent International is in advanced talks to acquire Baxter International Inc's (NYSE: BAX)